Concepedia

Ramakrishna Dumpati

RD

4

Publications

48

Citations

4

H-Index

2016

Active since

Affiliations

Osmania University(Current)

Ramakrishna Dumpati is an author at Osmania University specializing in medicine, drug discovery, and molecular docking.

Top concepts

MedicineDrug DiscoveryBiochemistryPharmacologyMolecular DockingDiabetesImmunologyCell BiologyCancer TherapyCell Signaling

Publications per year

2016–2018

4

Publications

4

Identification of New Lead Molecules Against UBE2NL Enzyme for Cancer Therapy

Vishwanath Ramatenki, Ramakrishna Dumpati, Rajender Vadija et al. · Applied Biochemistry and Biotechnology · 2017 · 14 citations

Cancer Therapy, Hit Identification, Biochemistry +6

Suppressor of Cytokine Signalling‐3 as a Drug Target for Type 2 Diabetes Mellitus: A Structure‐Guided Approach

Ramakrishna Dumpati, Ramasree Dulapalli, Bhargavi Kondagari et al. · ChemistrySelect · 2016 · 12 citations

Drug Target, Immunology, Immune Regulation +20

Targeting the ubiquitin-conjugating enzyme E2D4 for cancer drug discovery–a structure-based approach

Vishwanath Ramatenki, Ramakrishna Dumpati, Rajender Vadija et al. · Journal of Chemical Biology · 2016 · 12 citations · Full text

Drug Target, Biochemistry, Structural Bioinformatics +11

Structural insights into suppressor of cytokine signaling 1 protein‐ identification of new leads for type 2 diabetes mellitus

Ramakrishna Dumpati, Vishwanath Ramatenki, Rajender Vadija et al. · Journal of Molecular Recognition · 2018 · 10 citations

Rows per page

1–4 of 4